Dolmetsch, Ricardo,Gasparini, Fabrizio,Gomez-Mancilla, Baltazar,Johns, Donald
申请号:
AU2018310881
公开号:
AU2018310881A1
申请日:
2018.07.30
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
The invention relates to the use of mavoglurant, or a pharmaceutically acceptable salt thereof: in the reduction of cocaine use by a cocaine use disorder patient; in preventing relapse into cocaine use by a cocaine use disorder patient; in the promotion of cocaine abstinence by a cocaine use disorder patient; in the treatment of the symptoms of depression or anxiety associated with cocaine use disorder.